Loading...
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review
PURPOSE: BRCA mutation carriers have an increased risk of developing breast or ovarian cancer. Risk-reducing bilateral salpingo-oophorectomy (RRBSO) is associated with a decrease in risk for tubal and ovarian cancer. Hormone replacement therapy (HRT) may increase breast, ovarian, and endometrial can...
Na minha lista:
| Udgivet i: | J Cancer Res Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164576/ https://ncbi.nlm.nih.gov/pubmed/33885953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03629-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|